bottom-fishing $IONS
Its antisense technology platform has served as a springboard for drug discovery and realized hope for patients with unmet needs. Its broad, diverse pipeline has more than 40 potential first-in-class and/or best-in-class medicines designed to treat a broad range of diseases.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.